Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07198113 · ClinicalTrials.gov registry record
COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- 1,100
- Enrollment target
NCT07198113 is a clinical trial that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1,100 participants.
The verdict
NCT07198113 is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- 1,100 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the clinical effectiveness and safety of newer inflammatory bowel disease (IBD) medications in anti-tumor necrosis factor (TNF) refractory patients with pediatric IBD (PIBD). Refractory means that there was no clinical response to anti-tumor necrosis factor (TNF) drugs or that the if there was a response, it is no longer present. The main question this study aims to answer is: Are the newer medications used to treat IBD just as safe and effective for treating IBD in children. Participants will already be taking these newer medications as assigned by their regular health care provider.Participants' care will be managed by their regular healthcare provider as part of usual (standard) care for those with PIBD. While taking these medications, participants will be asked to answer questions about their symptoms and health periodically over the course of the study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2028-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07198113
The ClinicalTrials.gov registry entry for NCT07198113 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07198113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07198113 about?
NCT07198113 is a clinical study titled "COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)". The purpose of the study is to compare the clinical effectiveness and safety of newer inflammatory bowel disease (IBD) medications in anti-tumor necrosis factor (TNF) refractory patients with pediatric IBD (PIBD). Refractory means that there was no clinical response to anti-tumor necrosis factor (TN...
What is the current status of trial NCT07198113?
This trial is currently recruiting. The enrollment target is 1,100 participants. The study started on 2025-11-01. Estimated completion is 2028-09.
Who is sponsoring clinical trial NCT07198113?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.